- active not recruitingPHASE3
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
This study looks at a new medicine called Setmelanotide for people aged 4 and over with a weight problem called hypothalamic obesity. It aims to see if the medicine helps with weight, hunger, and quality of life.
United States · Canada · Germany - recruitingPHASE3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
This study looks at a new medicine called Setmelanotide for children and adults aged 4 and over with a certain type of obesity called hypothalamic obesity. Researchers want to see if it helps with weight, hunger, and quality of life.
United States · United Kingdom - enrolling by invitationPHASE2
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
This study looks at a new medicine called Bivamelagon for people with a condition called Hypothalamic Obesity (HO). It's a long-term study, lasting up to two years, for those who have already tried Bivamelagon in an earlier study and found it safe and tolerable.
United States · United Kingdom